Based on prior findings that Akt and Erk1/2 signalling pathways contribute to DARPP-32 mediated breast and gastric oncogenesis, we sought to elucidate their potential role in SCLC tumour growth. The gene discussed is PPP1R1B; the disease is neoplasm.